IP Library Granted Patent US 9,475,838
Granted Patent B2
US 9,475,838 · App. 14/886,794 · Granted Oct 25, 2016

Process for purification of a fatty acid binding protein

Inventors: Miriam Tendler (Rio de Janeiro, BR); Celso Raul Romero Ramos (Rio de Janeiro, BR); Andrew J. G. Simpson (New York, NY)
Assignees: OURO FINO AGRONEGOCIO LTDA.; FUNDACAO OSWALDO CRUZ
C07K1/36C07K14/395C07K14/43559C12N15/815A61K38/00A61K39/0003
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,475,838
App. No.
14/886,794
Granted
Oct 25, 2016
Kind
B2
Abstract

A process for purification of a fatty acid binding proteins such as, e.g., Sm14 of Pichia pastoris or type-3 FABP protein of Fasciola hepatica . The process includes the steps of: (a) performing lysis of cells containing the fatty acid binding protein to obtain a lysate; (b) clarifying the lysate obtained in step (a) to obtain a clarified lysate; (c) loading the clarified lysate in a column containing an anion exchange resin; (d) eluting proteins from the column by pH changes in the column; and (e) separating contaminant proteins from the fatty acid binding protein by gel-filtration.

Claims (12)

1. A process for purification of a recombinant Sm14 Schistosoma mansoni protein, said process comprising the steps of:

(a) performing lysis of cells containing the Sm14 protein to obtain a lysate;

(b) clarifying the lysate obtained in step (a) to obtain a clarified lysate;

(c) loading the clarified lysate in a column containing an anion exchange resin;

(d) eluting proteins from the column by pH changes in the column; and

(e) separating contaminant proteins from the Sm14 protein by gel-filtration, wherein said Sm14 protein is encoded by SEQ ID NO:3 and is expressed in Pichia pastoris.

2. The process according to claim 1 , wherein the lysis performing step comprises resuspending the cells in 30 mM Tris-HCl 30 mM pH 9.5 buffer and lysing the cells with a French press.

3. The process according to claim 2 , wherein the clarifying step comprises centrifugation.

4. The process according to claim 3 , wherein the loading step comprises loading the column with the clarified lysate in 30 mM Tris-HCl pH 9.5 buffer.

5. The process according to claim 4 , wherein the eluting step comprises eluting the fatty acid binding protein from the column with 30 mM Tris-HCl pH 8.0 buffer.

6. The process according to claim 5 , wherein the anion exchange resin comprises a quaternary amine in a matrix of cross-linked agarose with dextran surface extenders.

7. The process according to claim 6 , wherein the separating step comprises gathering and concentrating eluted fractions from the eluting step, applying the eluted fractions to a gel filtration column containing size exclusion media comprised of the anion exchange resin allyl dextran and N,N′-methylene bisacrylamide, using phosphate buffered saline pH 7.4 as a mobile phase.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 9, 2019
From: OURO FINO AGRONEGOCIO LTDA
To: FUNDACAO OSWALDO CRUZ
Reel/Frame 050313/0038 →
MERGER Recorded Mar 11, 2016
From: ALVOS - CONSULTORIA, DESENVOLVIMENTO E COMMERCIALIZACAO DE PRODUTOS BIOTECNOLOGICOS S/A
To: OURO FINO AGRONEGOCIO LTDA.
Reel/Frame 038067/0182 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 19, 2015
From: TENDLER, MIRIAM; RAMOS, CELSO RAUL ROMERO; SIMPSON, ANDREW J. G.
To: FUNDACAO OSWALDO CRUZ; ALVOS - CONSULTORIA, DESENVOLVIMENTO E COMERCIALIZACAO DE PRODUTOS BIOTECNOLOGICOS S/A
Reel/Frame 036824/0504 →
Priority Claims (1)
BR 1005855 · Sep 17, 2010 · national
Continuity (2)
Division 13824378
Related Publication 20160052963A1 · Feb 25, 2016